CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 39 enrolled
Drug / intervention
citalopram +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02386475
NCT02386475Phase 4Completed
CompareCT.gov

Effect of Serotonin and Levodopa Functional Recovery in Patients With Cerebral Infarction

Hospital de Granollers·interventional·Posted Mar 12, 2015·Updated Nov 26, 2019

In Brief

A Phase 4 clinical trial evaluating placebo, citalopram, and 1 other intervention for Stroke. Completed, enrolled 39 participants across 1 site.

Detailed Summary

Cortical plasticity plays a pivotal role in functional recovery after a stroke. Neurotransmitter release, facilitates the creation of new synapses and promotes brain plasticity. In a pilot study, will evaluate the potential benefit of drugs that increase the release of neurotransmitters in patients with first stroke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesSpain
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 12, 2015
Enrollment StartJan 1, 2015
Primary CompletionMar 1, 2017
Study CompletionOct 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.3 years ago

Interventions

placeboother

In all cases, regardless of the assigned treatment group, will follow usual physiotherapy program and vascular risk factors, and treatment of stroke will be controlled according to current recommendations of the American Heart Association / American Stroke Association.

citalopramdrug

In all cases, regardless of the assigned treatment group, will follow usual physiotherapy program and vascular risk factors, and treatment of stroke will be controlled according to current recommendations of the American Heart Association / American Stroke Association.

sinemet plusdrug

In all cases, regardless of the assigned treatment group, will follow usual physiotherapy program and vascular risk factors, and treatment of stroke will be controlled according to current recommendations of the American Heart Association / American Stroke Association.